Matches in Wikidata for { <http://www.wikidata.org/entity/Q92161460> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q92161460 description "article scientifique publié en 2019" @default.
- Q92161460 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92161460 description "scientific article published on 18 December 2019" @default.
- Q92161460 description "wetenschappelijk artikel" @default.
- Q92161460 description "наукова стаття, опублікована 18 грудня 2019" @default.
- Q92161460 name "Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells" @default.
- Q92161460 name "Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells" @default.
- Q92161460 type Item @default.
- Q92161460 label "Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells" @default.
- Q92161460 label "Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells" @default.
- Q92161460 prefLabel "Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells" @default.
- Q92161460 prefLabel "Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells" @default.
- Q92161460 P1433 Q92161460-ABED9AA7-D858-4FBE-8F1E-830F33AD9849 @default.
- Q92161460 P1476 Q92161460-9F57962F-B594-49C0-B78D-B51881ADAAAD @default.
- Q92161460 P2093 Q92161460-0D05D461-73B2-4C44-A203-EA32722843BA @default.
- Q92161460 P2093 Q92161460-1F762D95-9AC1-4A1A-87D1-81DB7FB5FA68 @default.
- Q92161460 P2093 Q92161460-439C8AC4-62EB-4753-9026-B1A1D9D7EBA6 @default.
- Q92161460 P2093 Q92161460-5323EE92-C5FB-480F-8D97-D79A9455F192 @default.
- Q92161460 P2093 Q92161460-B3AB46E2-4BF4-48EA-B46B-CED4B3458133 @default.
- Q92161460 P2093 Q92161460-CEA9CC54-2386-4038-A736-5187EBF300ED @default.
- Q92161460 P304 Q92161460-290AA80E-69E0-49D8-A82B-38C3E8B1615D @default.
- Q92161460 P31 Q92161460-DD050D84-FB4B-4E21-A1C0-41B014EEDCEE @default.
- Q92161460 P356 Q92161460-AF92DD5D-9FA3-46B9-9978-3FB83CA5287E @default.
- Q92161460 P478 Q92161460-F8E69E37-E5B5-4490-9799-E8B17B8A4125 @default.
- Q92161460 P577 Q92161460-8FDD4C40-E694-448F-9BC6-F13E1CF53EDB @default.
- Q92161460 P698 Q92161460-45C1F28D-0E6E-4193-9173-4A45B4044F2F @default.
- Q92161460 P921 Q92161460-4963ED49-04E6-4B5C-9AF9-9624CCDD97F5 @default.
- Q92161460 P356 J.MOLIMM.2019.11.008 @default.
- Q92161460 P698 31862674 @default.
- Q92161460 P1433 Q6895954 @default.
- Q92161460 P1476 "Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells" @default.
- Q92161460 P2093 "Doxakis Anestakis" @default.
- Q92161460 P2093 "Drosos Tsavlis" @default.
- Q92161460 P2093 "Kalliopi Domvri" @default.
- Q92161460 P2093 "Paul Zarogoulidis" @default.
- Q92161460 P2093 "Savvas Petanidis" @default.
- Q92161460 P2093 "Theodora Katopodi" @default.
- Q92161460 P304 "99-109" @default.
- Q92161460 P31 Q13442814 @default.
- Q92161460 P356 "10.1016/J.MOLIMM.2019.11.008" @default.
- Q92161460 P478 "118" @default.
- Q92161460 P577 "2019-12-18T00:00:00Z" @default.
- Q92161460 P698 "31862674" @default.
- Q92161460 P921 Q415588 @default.